Skip to main content
Circio Holding ASA logo

Circio Holding ASA — Investor Relations & Filings

Ticker · CRNA ISIN · NO0013033795 LEI · 5967007LIEEXZXFYNS31 OL Professional, scientific and technical activities
Open in API
Filings indexed 181 across all filing types
Latest filing 2026-06-04 Director's Dealing
Country NO Norway
Listing OL CRNA

About Circio Holding ASA

https://www.targovax.com/en/

Circio Holding ASA is a clinical-stage company developing novel medicines based on circular RNA (circRNA) and immunotherapy. The company's core focus is its proprietary circVec platform, a circular RNA expression system designed to enhance the efficacy and durability of gene and cell therapies. Circio's development pipeline is directed towards immuno-oncology, targeting difficult-to-treat solid tumors, and the application of its circRNA technology to address genetic diseases.

Recent filings

Filing Released Lang Actions
Circio Holding ASA Exercise of Warrants by primary insiders - Attachment: Notification Of Trade By Primary Insiders Exercised Warrants.pdf
Director's Dealing Classification · 99% confidence The document is a notification of insider transactions detailing exercises of warrants by the CTO and a closely associated party, including instrument ISINs, volumes, prices, dates, and insider roles. This matches the definition of a Director’s Dealing (report of personal share transactions by company directors and executives).
2026-06-04 English
Circio Holding ASA Exercise of Warrants by primary insiders
Director's Dealing Classification · 92% confidence The document is a stock exchange announcement detailing warrant exercises by primary insiders (company officers) resulting in personal share allocations. This fits the definition of Director's Dealing (insider transactions by executives). It is not an overall report nor a capital update by the company itself.
2026-06-04 English
Circio Holding ASA: Last day of trading in warrants
Share Issue/Capital Change Classification · 78% confidence The document is a formal press release notifying investors of the last trading day for equity warrants issued in connection with a recent rights issue and private placement. It does not contain financial results, board changes, or meeting materials, nor is it a full report; rather it pertains directly to an equity capital event (the issuance and trading of warrants). This fits the definition of a share issue/capital change announcement (SHA).
2026-06-03 English
Circio Holding ASA Exercise of Warrants by primary insiders - Attachment: Notification Of Trade By Primary Insiders Exercised Warrants.pdf
Director's Dealing Classification · 90% confidence The document is a notification by primary insiders (COO and CSO) of their personal transactions (exercise of warrants into shares) in Circio Holding ASA. This is an insider dealing report. It is not a share buyback by the company (which would be POS), but a director’s personal transaction. Therefore, the correct category is Director’s Dealing (DIRS).
2026-06-02 English
Circio Holding ASA Exercise of Warrants by primary insiders
Director's Dealing Classification · 98% confidence The document is a stock exchange announcement detailing warrant exercises by primary insiders (executives) of the company, including quantities, dates, and resulting holdings. This clearly describes insider share transactions by directors/executives. According to the filing definitions, this matches “Director's Dealing (DIRS): Report of personal share transactions by company directors and executives.”
2026-06-02 English
Circio and GenAssist jointly announce gene therapy research collaboration for muscle diseases and in vivo cell therapy
Regulatory Filings Classification · 25% confidence The document is a joint corporate press release announcing a research collaboration between Circio and GenAssist. It contains no financial statements, voting results, regulatory certifications, or detailed report attachments. It does not fit into categories for financial reports, board changes, capital updates, or other specialized filings. Consequently, it falls under the fallback category for general regulatory and corporate announcements (RNS).
2026-06-01 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.